Incresync 25/15 Mg 28 Tablet

Incresync Alogliptin + Pioglitazone 25/15 mg Anti-Diabetic Tablets – 28 Count

Oral combination tablets containing alogliptin and pioglitazone, used to help improve blood glucose control in adults with type 2 diabetes mellitus, as part of diet and exercise or in combination with other antidiabetic medications.

Indications for Use

• Improving glycemic control in adults with type 2 diabetes mellitus.
• As adjunct therapy when single-agent treatment does not sufficiently control blood glucose.

Benefits and Features

• Combines two mechanisms of action to support glucose control.
• Helps improve insulin sensitivity and reduce blood glucose levels.
• Oral tablet form for once-daily administration as prescribed.

Directions for Use

• Take one tablet orally once daily, with or without food, or as directed by a healthcare professional.
• Follow the dosing instructions provided by your healthcare provider.

Warnings and Precautions

• Not indicated for type 1 diabetes or diabetic ketoacidosis.
• Inform your healthcare professional if you have heart, liver, or other systemic conditions.
• Blood glucose monitoring may be required during therapy.
• Keep out of reach of children and store in a cool, dry place.